BIOZOL holds an exclusive licence from the German Cancer Research Center (DKFZ, Heidelberg, Germany) for the production and worldwide distribution of the anti-IDH1 R132H antibody clone H09.

The anti-IDH1R132H Antibody is marketed under BIOZOL´s own brand dianova.

This highly specific antibody was developed for robust FFPE staining on brain tumor specimen in the unit of Prof. Dr. Andreas von Deimling, Department of Neuropathology, University Heidelberg / Clinical Cooperation Unit Neuropathology, German Cancer Research Center.


BIOZOL Diagnostica Vertrieb GmbH
Leipziger Straße 4
85386 Eching, Germany

main website: www.biozol.de
email: info@biozol.de